CompletedNot Applicable

The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease

China10,000 participantsStarted 2015-01-01

Plain-language summary

This is a retrospective observational cohort study (MRN-PND), aiming to explore the utility of contrast-enhanced MRN (ceMRN) compared to plain MRN in diagnosing peripheral nerve diseases and predicting the prognosis of patients with these conditions. Additionally, artificial intelligence (AI) methods are employed to enhance the diagnostic accuracy of MRN for peripheral nerve diseases and to precisely predict disease outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who underwent MRN scanning at Wuhan Union Hospital between January 2015 and January 2025;
✓. Age \> 18 years;
✓. Definitive clinical diagnosis (either healthy individuals or patients with a specific condition).

Exclusion criteria

✕. Poor quality of imaging;
✕. Incomplete clinical data or loss to follow-up;
✕. Unclear clinical diagnosis.

What they're measuring

Correlation analysis of MR information and diagnosis outcome

Timeframe: 0.5 year

Trial details

NCT IDNCT06843642

SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Peripheral Nerve Disease trials